Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BNBX

BNB Plus Corp

Apr 10 • 04:00PM ET

0.5800

-0.0381 -6.16 %

Financial • Asset Management • USA • NASD

Peers: ILMN ONC FATE QGEN CRSP EDIT GH NTLA PACB TWST

| Held by: VXF DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-269.56	Insider Own	6.55%	Shs Outstand	5.45M	Perf Week	-11.65%
Market Cap	3.29M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.30M	Perf Month	-22.77%
Enterprise Value	-0.24M	PEG	-	EPS next Q	-	Inst Own	5.97%	Short Float	0.03%	Perf Quarter	-64.20%
Income	-70.57M	P/S	1.60	EPS this Y	-	Inst Trans	25.68%	Short Ratio	0.03	Perf Half Y	-86.54%
Sales	2.05M	P/B	0.15	EPS next Y	-	ROA	-167.94%	Short Interest	0.00M	Perf YTD	-52.85%
Book/sh	3.95	P/C	1.03	EPS next 5Y	-	ROE	-194.93%	52W High	19.80 -97.07%	Perf Year	-96.48%
Cash/sh	0.56	P/FCF	-	EPS past 3/5Y	78.76% 69.38%	ROIC	-374.64%	52W Low	0.60 -3.01%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-51.00% 2.04%	Gross Margin	7.26%	Volatility	6.95% 8.16%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-0.12	EPS Y/Y TTM	93.71%	Oper. Margin	-1166.60%	ATR (14)	0.06	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	2.28	Sales Y/Y TTM	-45.07%	Profit Margin	-3437.97%	RSI (14)	28.58	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.32	EPS Q/Q	99.50%	SMA20	-17.14%	Beta	0.70	Target Price	1125.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-52.75%	SMA50	-27.33%	Rel Volume	1.04	Prev Close	0.62
Employees	26	LT Debt/Eq	0.00	Earnings	-	SMA200	-78.77%	Avg Volume	60.57K	Price	0.58
IPO	Oct 18, 2001	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	62,759	Change	-6.16%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-21	Initiated	ROTH Capital	Buy	$24
Jan-14-21	Reiterated	H.C. Wainwright	Buy	$18 → $14
Dec-18-20	Reiterated	H.C. Wainwright	Buy	$20 → $12
Jul-20-20	Reiterated	H.C. Wainwright	Buy	$18 → $22
Jul-02-20	Initiated	H.C. Wainwright	Buy	$18
Nov-14-16	Reiterated	Maxim Group	Buy	$8 → $6
May-13-16	Reiterated	Maxim Group	Buy	$13 → $9
Oct-08-15	Reiterated	Maxim Group	Buy	$9 → $13
May-26-15	Initiated	The Benchmark Company	Speculative Buy	$5
Feb-10-15	Reiterated	Maxim Group	Buy	$7 → $9
Jan-13-15	Initiated	Maxim Group	Buy	$7

Show Previous Ratings

Mar-18-26 08:00AM	BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea IVT Platform (Business Wire)
Feb-24-26 07:00AM	BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA from Genetic Medicine Developers (Business Wire)
Feb-05-26 08:00AM	BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director (Business Wire) -31.72%
Jan-28-26 10:01AM	BNB Plus Corp.: Bet on Binance Ecosystem with Best-in-Class Yield Exec Edge Initiation Report (Exec Edge)
Jan-27-26 08:00AM	BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th (Business Wire)
08:01AM	Loading…
Jan-05-26 08:01AM	BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA Order (Business Wire) -8.11%
Dec-18-25 08:00AM	BNB Plus Corp. (BNBX) Announces Largest Ever Shipment of LineaDNATM (Business Wire)
Dec-10-25 09:40AM	BNB Plus acquires 3,349 additional BNB tokens for approximately $3M (TipRanks)
Dec-09-25 08:00AM	BNB Plus Provides BNB Treasury and Operational Updates (Business Wire)
Nov-17-25 08:00AM	Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board (Business Wire)
Oct-28-25 08:00AM	BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update (Business Wire)
Oct-22-25 08:00AM	Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million (Business Wire) +40.35%
Oct-16-25 02:37PM	Inside the Crypto Stock Frenzy: How a $58 Million BNB Bet Sent Applied DNA Into Chaos (GuruFocus.com) -6.30%
Oct-15-25 08:30AM	Applied DNA Sciences Becomes a B2i Digital Featured Company to Share Its Strategic Rebrand and BNB-Focused Treasury Shift With Investors (NewMediaWire)
Oct-06-25 08:00AM	Applied DNA Sciences to Begin Trading Under New Ticker 'BNBX' Reflecting Digital Asset Treasury Strategy (Business Wire) +31.62%
03:08PM	Loading…
Sep-29-25 03:08PM	Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation (Business Wire) +26.33%
Sep-23-25 08:30AM	Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences (ACCESSWIRE)
Aug-14-25 05:32PM	Applied DNA Sciences: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Applied DNA Reports Third Quarter Fiscal 2025 Financial Results (ACCESSWIRE)
Jul-24-25 09:00AM	Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application (ACCESSWIRE)
Jul-07-25 09:00AM	Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements (ACCESSWIRE) +9.07%
Jun-30-25 09:00AM	Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx (ACCESSWIRE) +6.63%
Jun-17-25 04:10PM	Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward (ACCESSWIRE) -7.62%
Jun-16-25 09:00AM	Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August (ACCESSWIRE) +9.52%
May-29-25 04:05PM	Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 (ACCESSWIRE) -36.88%
08:00AM	Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 (ACCESSWIRE)
May-15-25 05:32PM	Applied DNA Sciences: Fiscal Q2 Earnings Snapshot (Associated Press Finance) -17.28%
04:05PM	Applied DNA Reports Second Quarter Fiscal 2025 Financial Results (ACCESSWIRE)
May-14-25 11:30AM	Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3 (ACCESSWIRE) +5.62%
Apr-21-25 09:00AM	Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA (ACCESSWIRE)
09:00AM	Loading…
Apr-08-25 09:00AM	Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement (ACCESSWIRE) -13.08%
Apr-01-25 09:45AM	Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement (ACCESSWIRE)
Mar-26-25 09:00AM	Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test (ACCESSWIRE)
Mar-12-25 08:00AM	Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 (ACCESSWIRE) -56.80%
Feb-14-25 02:20AM	Applied DNA Sciences Inc (APDN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ... (GuruFocus.com)
Feb-13-25 05:20PM	Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -8.22%
04:18PM	Applied DNA Sciences: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress (ACCESSWIRE)
Feb-12-25 12:00PM	Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025 (ACCESSWIRE)
Feb-11-25 08:30AM	Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14 (ACCESSWIRE) +7.34%
Jan-10-25 09:00AM	Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates (ACCESSWIRE)
Jan-08-25 04:30PM	Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter (ACCESSWIRE) -13.46%
Dec-18-24 09:00AM	Applied DNA Customer UHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA (ACCESSWIRE)
09:00AM	Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA (ACCESS Newswire)
Dec-17-24 05:15PM	Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +24.46%
04:12PM	Applied DNA Sciences: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines (ACCESSWIRE)
Dec-16-24 10:00AM	Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out (ACCESSWIRE) +12.27%
Oct-30-24 07:15AM	Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement (ACCESSWIRE) -40.56%
Oct-15-24 10:30AM	Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 (ACCESSWIRE)
Sep-18-24 09:00AM	Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement (ACCESSWIRE)
Sep-17-24 09:15AM	Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit (ACCESSWIRE)
09:00AM	Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application (ACCESSWIRE)
Sep-11-24 09:00AM	Applied DNA Launches Mpox Clade I and Clade II Testing Service (ACCESSWIRE) +17.97%
Sep-04-24 09:00AM	Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan (ACCESSWIRE) -21.05%
Sep-03-24 11:53PM	Applied DNA Sciences, Inc. (APDN): A Hot Penny Stock On The Move (Insider Monkey) -20.42%
Sep-02-24 12:17PM	10 Hot Penny Stocks On the Move (Insider Monkey)
Aug-23-24 09:00AM	Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I (ACCESSWIRE) +38.80%
Aug-19-24 03:25PM	Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I (ACCESSWIRE) +128.64%
Aug-08-24 04:10PM	Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results (ACCESSWIRE) -6.82%
Aug-07-24 08:00AM	Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024 (ACCESSWIRE) -6.10%
Jul-29-24 11:57AM	CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit (ACCESSWIRE)
11:10AM	Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit (ACCESSWIRE)
Jul-25-24 09:00AM	Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability (ACCESSWIRE)
Jul-18-24 10:00AM	U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract (ACCESSWIRE)
Jul-10-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jul-02-24 07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) -19.25%
Jun-27-24 12:00PM	Applied DNA Sciences (APDN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jun-20-24 09:15AM	Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics (ACCESSWIRE) +5.45%
Jun-18-24 09:00AM	Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing (ACCESSWIRE)
Jun-13-24 09:00AM	Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health (ACCESSWIRE) +6.45%
Jun-05-24 09:00AM	Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform (ACCESSWIRE) +16.48%
May-28-24 09:30AM	Applied DNA Announces Pricing of $12 Million Public Offering (ACCESSWIRE) -69.85%
May-13-24 08:55AM	Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML (ACCESSWIRE) -10.72%
May-10-24 08:53PM	APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -7.75%
05:15PM	Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results (ACCESSWIRE)
09:00AM	Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement (ACCESSWIRE)
May-09-24 05:21AM	Xinjiang cotton widespread despite US UFLPA legislation (Just Style)
May-07-24 12:22PM	Banned Chinese cotton found in 19% of US and global retailers' merchandise, study shows (Reuters)
12:17PM	CORRECTED-Banned Chinese cotton found in 19% of US and global retailers' merchandise, study shows (Reuters)
Apr-25-24 09:00AM	Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program (ACCESSWIRE)
Apr-22-24 04:05PM	Applied DNA Announces 1-For-20 Reverse Stock Split (ACCESSWIRE) -12.12%
Mar-18-24 09:00AM	Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start (ACCESSWIRE) +19.57%
Mar-14-24 10:00AM	Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress (ACCESSWIRE) -23.08%
Feb-21-24 09:40AM	Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year? (Zacks)
Feb-10-24 08:48AM	Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 06:17AM	Q1 2024 Applied DNA Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-08-24 05:40PM	Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:40PM	Applied DNA Sciences: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results (ACCESSWIRE)
Feb-05-24 01:00PM	Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 (ACCESSWIRE)
Feb-02-24 04:15PM	Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE)
Jan-31-24 08:00AM	Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE)
Dec-14-23 08:00AM	Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnologys mRNA Manufacturing Workflow (ACCESSWIRE) -7.89%
Dec-12-23 08:10AM	Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript (Insider Monkey) -19.96%
Dec-07-23 09:55PM	APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -18.43%
04:55PM	Applied DNA Sciences: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results (ACCESSWIRE)
Dec-05-23 08:30AM	Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 (ACCESSWIRE)

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNBX

BNB Plus Corp

Upgrade your Finviz experience